Pro- and anti-epileptic roles of microglia

Shinichi Kinoshita1, Ryuta Koyama1

  • 1Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.

Insights

Microglia, the brain's immune cells, display distinct forms in epilepsy. Understanding these microglial phenotypes is key to determining their role in seizure activity and brain health.

Area of Science:

  • Neuroimmunology
  • Epileptology
  • Cellular Biology

Background:

  • Microglia are crucial for brain homeostasis and exhibit diverse activation states during epileptogenesis.
  • The specific roles of different microglial phenotypes in epilepsy remain poorly understood.
  • Mesial temporal lobe epilepsy presents distinct microglial morphologies: amoeboid in sclerotic regions and ramified in non-sclerotic areas.

Purpose of the Study:

  • To review the distinct roles of amoeboid and ramified microglia in epilepsy.
  • To elucidate the pro-epileptic versus anti-epileptic functions of these microglial phenotypes.
  • To explore their involvement in inflammatory responses, neurogenesis, and neuron-microglia interactions.

Main Methods:

  • Literature review of studies on microglial phenotypes in epilepsy.
  • Analysis of morphological and functional differences between amoeboid and ramified microglia.
  • Examination of their roles in inflammatory signaling, neurogenesis, and synaptic function.

Main Results:

  • Distinct microglial morphologies correlate with different brain regions in epilepsy.
  • Evidence suggests differential involvement of microglial phenotypes in neuroinflammation.
  • The impact of microglial phenotypes on neurogenesis and neuronal interactions varies.

Conclusions:

  • Microglial phenotypes in epilepsy have distinct, context-dependent roles.
  • Further research is needed to precisely define the pro- or anti-epileptic functions of each microglial type.
  • Targeting specific microglial phenotypes may offer novel therapeutic strategies for epilepsy.

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
708
Nervous Tissue: Glial Cells01:31

Nervous Tissue: Glial Cells

Glia, or neuroglia, are vital support cells that assist neurons in their functions. The term "glia" originates from the Greek word for "glue," reflecting their role in holding the nervous system together. These cells can be categorized into six types: four in the central nervous system (CNS) and two in the peripheral nervous system (PNS).
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
5.8K
Glial Cells01:04

Glial Cells

Overview
91.8K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
969
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
910
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
631